Latest & greatest articles for myocardial infarction

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on myocardial infarction or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on myocardial infarction and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for myocardial infarction

1. Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults

Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health (...) Infarction in Young Adults , , , , , Affiliations Expand Affiliations 1 Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. 2 Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. Electronic address: ann.navar@duke.edu. PMID: 32762899 PMCID: PMC7444655 (available on 2021-08-11 ) DOI: Item in Clipboard Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults Michel Zeitouni et al. J Am

2020 EvidenceUpdates

2. Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest

Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health (...) Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest Koen Ameloot et al. J Am Coll Cardiol . 2020 . Show details Display options Display options Format J Am Coll Cardiol Actions . 2020 Aug 18;76(7):812-824. doi: 10.1016/j.jacc.2020.06.043. Authors , , , , , , , , , , , , , , , , , , Affiliations 1 Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Department of Cardiology, University Hospitals Leuven, Leuven, Belgium; Faculty of Medicine and Life Sciences

2020 EvidenceUpdates

3. B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial

B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health (...) after myocardial infarction: a randomised trial , , , , , , Affiliations Expand Affiliations 1 Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA hubers.scott@mayo.edu. 2 Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. 3 Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA. 4 Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida, USA. PMID: 32747497 DOI: Item in Clipboard B-type natriuretic peptide

2020 EvidenceUpdates

4. Sex Differences in Outcomes After Myocardial Infarction in the Community

Sex Differences in Outcomes After Myocardial Infarction in the Community Sex Differences in Outcomes After Myocardial Infarction in the Community - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: . Get the latest research from NIH (...) Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Am J Med Actions . 2020 Jul 3;S0002-9343(20)30542-8. doi: 10.1016/j.amjmed.2020.05.040. Online ahead of print. Sex Differences in Outcomes After Myocardial Infarction in the Community , , , , , , , Affiliations

2020 EvidenceUpdates

5. Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data. (Full text)

Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data. Previous trials suggest lower long-term risk of mortality after invasive rather than non-invasive management of patients with non-ST elevation myocardial infarction (NSTEMI), but the trials excluded very elderly patients. We aimed to estimate the effect of invasive versus non-invasive management within 3 days of peak troponin

2020 Lancet PubMed abstract

6. Comparison of Late Cardiac Death and Myocardial Infarction Rates in Women Vs Men With ST-Elevation Myocardial Infarction

Comparison of Late Cardiac Death and Myocardial Infarction Rates in Women Vs Men With ST-Elevation Myocardial Infarction Comparison of Late Cardiac Death and Myocardial Infarction Rates in Women Vs Men With ST-Elevation Myocardial Infarction - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions . 2020 Aug 1;128:120-126. doi: 10.1016/j.amjcard.2020.04.044. Epub 2020 May 13. Comparison of Late Cardiac Death and Myocardial Infarction Rates in Women Vs Men With ST-Elevation

2020 EvidenceUpdates

7. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction

Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions . 2020 Aug 4;76(5):518-529. doi: 10.1016/j.jacc.2020.06.017. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction

2020 EvidenceUpdates

8. Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial. (Abstract)

Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial. Thyroid hormones play a key role in modulating myocardial contractility. Subclinical hypothyroidism in patients with acute myocardial infarction is associated with poor prognosis.To evaluate the effect of levothyroxine treatment on left ventricular function in patients with acute myocardial infarction and subclinical (...) hypothyroidism.A double-blind, randomized clinical trial conducted in 6 hospitals in the United Kingdom. Patients with acute myocardial infarction including ST-segment elevation and non-ST-segment elevation were recruited between February 2015 and December 2016, with the last participant being followed up in December 2017.Levothyroxine treatment (n = 46) commencing at 25 µg titrated to aim for serum thyrotropin levels between 0.4 and 2.5 mU/L or identical placebo (n = 49), both provided in capsule form, once

2020 JAMA

9. Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction (Full text)

Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology (...) Actions Cite Share Permalink Copy Page navigation Eur Heart J Actions . 2020 Jun 9;ehaa375. doi: 10.1093/eurheartj/ehaa375. Online ahead of print. Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction , , , , , , , , , , , Affiliations Expand Affiliations 1 BHF Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, EH16 4SB Edinburgh, UK. 2 Department of Medicine, Karolinska Institute, 171 77 Solna, Stockholm, Sweden. 3 Functional

2020 EvidenceUpdates PubMed abstract

10. Effect of Smartphone-Enabled Health Monitoring Devices vs Regular Follow-up on Blood Pressure Control Among Patients After Myocardial Infarction: A Randomized Clinical Trial (Full text)

Effect of Smartphone-Enabled Health Monitoring Devices vs Regular Follow-up on Blood Pressure Control Among Patients After Myocardial Infarction: A Randomized Clinical Trial Effect of Smartphone-Enabled Health Monitoring Devices vs Regular Follow-up on Blood Pressure Control Among Patients After Myocardial Infarction: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History (...) for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Netw Open Actions . 2020 Apr 1;3(4):e202165. doi: 10.1001/jamanetworkopen.2020.2165. Effect of Smartphone-Enabled Health Monitoring Devices vs Regular Follow-up on Blood Pressure Control Among Patients After Myocardial Infarction: A Randomized Clinical Trial , , , , , , Affiliations Expand Affiliation 1

2020 EvidenceUpdates PubMed abstract

11. Meta-Analysis of Optimal Revascularization Strategy for Patients With ST-Segment Elevation Myocardial Infarction and Multi-Vessel Coronary Artery Disease

Meta-Analysis of Optimal Revascularization Strategy for Patients With ST-Segment Elevation Myocardial Infarction and Multi-Vessel Coronary Artery Disease Meta-Analysis of Optimal Revascularization Strategy for Patients With ST-Segment Elevation Myocardial Infarction and Multi-Vessel Coronary Artery Disease - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions . 2020 May 16;S0002-9149(20)30492-6. doi: 10.1016/j.amjcard.2020.05.016. Online ahead of print. Meta-Analysis of Optimal Revascularization Strategy for Patients With ST-Segment Elevation Myocardial Infarction and Multi-Vessel Coronary Artery Disease , , , , , , Affiliations Expand Affiliations 1 Alabama College

2020 EvidenceUpdates

12. Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial. (Full text)

Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial. To test a scalable health system intervention to improve long term adherence to secondary prevention treatments among patients who have had a recent myocardial infarction.Three arm, pragmatic randomised controlled trial with blinded outcome assessment.Nine cardiac centres in Ontario, Canada.2632 patients with obstructive coronary artery (...) disease after a myocardial infarction, identified from a centralised cardiac registry.Participants were randomised 1:1:1 to receive usual care, five mail-outs developed through a user centred design process, or mail-outs plus phone calls. The phone calls were delivered first by an interactive automated system to screen for non-adherence to treatment. Trained lay health workers followed up as necessary. Interventions were coordinated centrally but delivered from each patient's hospital site.Co-primary

2020 BMJ PubMed abstract

13. Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation (Full text)

Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes (...) Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Acad Emerg Med Actions . 2020 Mar 27. doi: 10.1111/acem.13922. Online ahead of print. Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 From the, Emergency Medicine, Baylor College of Medicine, Houston, TX. 2 the, Department

2020 EvidenceUpdates PubMed abstract

14. Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population

Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions . 2020 Jun 15;125(12):1823-1828. doi: 10.1016/j.amjcard.2020.03.026. Epub 2020 Apr 10. Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population , , , Affiliations Expand Affiliations 1 Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina. 2 Department of Internal Medicine, Section on Hospital

2020 EvidenceUpdates

15. Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis. (Full text)

Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis. To evaluate the prognosis of unrecognised myocardial infarction determined by electrocardiography (UMI-ECG) or cardiac magnetic resonance imaging (UMI-CMR).Systematic review and meta-analysis of prospective studies.Electronic databases, including PubMed, Embase, and Google Scholar.Prospective cohort studies were included if they reported (...) adjusted relative risks, odds ratios, or hazard ratios and 95% confidence intervals for all cause mortality or cardiovascular outcomes in participants with unrecognised myocardial infarction compared with those without myocardial infarction.The primary outcomes were composite major adverse cardiac events, all cause mortality, and cardiovascular mortality associated with UMI-ECG and UMI-CMR. The secondary outcomes were the risks of recurrent coronary heart disease or myocardial infarction, stroke, heart

2020 BMJ PubMed abstract

16. Management of Acute Myocardial Infarction During the COVID?19 Pandemic (Full text)

Management of Acute Myocardial Infarction During the COVID?19 Pandemic Management of acute myocardial infarction during the COVID‐19 pandemic - Mahmud - - Catheterization and Cardiovascular Interventions - Wiley Online Library COVID-19 campus closures: see options for to subscribed content. By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Core Curriculum Free Access Management of acute myocardial infarction during (...) is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID‐19 pandemic. It is critical to inform the public that we can minimize exposure to the coronavirus so they continue to call the emergency medical system (EMS) for acute ischemic heart disease symptoms and therefore get the appropriate level of cardiac care that their presentation warrants; target the use of primary percutaneous coronary intervention (PCI) or fibrinolysis

2020 Society for Cardiovascular Angiography and Interventions PubMed abstract

17. Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial (Full text)

Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show (...) . doi: 10.1016/j.jacc.2020.01.050. Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial , , , , , , , , , , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators Yoga-CaRe Trial Investigators : , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations 1 Centre for Chronic Disease Control, New Delhi, India; Public Health Foundation of India, New Delhi, India; London School of Hygiene

2020 EvidenceUpdates PubMed abstract

18. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease. (Abstract)

Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease. Multivessel coronary artery disease is found in 30-50% of patients with ST-elevation myocardial infarction (MI) and is associated with adverse outcomes. It is not yet clear if outcomes are improved by utilizing fractional flow reserve (FFR) guided percutaneous coronary

2020 Coronary artery disease

19. Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction. (Abstract)

Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction. Mononuclear cells (MNCs) have been tested in clinical trials across multiple cardiovascular pathologies with mixed results. Major adverse cardiac events (MACE) and markers of cardiovascular capacity have been particularly challenging to interpret because of small size. This meta-analysis is aimed to assess the efficacy of MNC therapy in randomized clinical trials (...) York Heart Association class, and MACE incidences were considered secondary outcomes.In short-term follow-up, patients treated with MNCs demonstrated a significant increase in absolute LVEF of 2.21% (95% CI 1.59-2.83; P < .001; I2 = 32%) and 6.01% (95% CI 4.45-7.57; P < .001; I2 = 0%) in acute myocardial infarction (AMI) and ischemic cardiomyopathy studies, respectively. This effect was sustained in long-term follow-up. MNC therapy significantly reduced left ventricular end-systolic volume; however

2020 American Heart Journal

20. The Prognostic Value of Early Repolarization Pattern for the Ventricular Tachyarrhythmias of Acute Myocardial Infarction Patients: A Meta-Analysis. (Abstract)

The Prognostic Value of Early Repolarization Pattern for the Ventricular Tachyarrhythmias of Acute Myocardial Infarction Patients: A Meta-Analysis. Several studies have indicated that early repolarization (ER) is a risk factor for ventricular tachyarrhythmias (VTAs) in acute myocardial infarction (AMI) patients. The prognostic values of ER detail characteristics except J-point morphology, and inferior leads ER location for VTAs are still unclear. We searched PubMed, Embase, and the Cochrane

2020 Cardiology